Compounds > indazoles
Page last updated: 2024-08-21

indazoles and sr141716

indazoles has been researched along with sr141716 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Morales, M; Oz, M; Zhang, L1
Carai, MA; Grella, GE; Lazzari, P; Loriga, G; Murineddu, G; Mussinu, JM; Pani, L; Pinna, GA; Ruiu, S1
Lazzari, P; Mastinu, A; Pani, L; Pinna, GA; Pira, M1
Dimmito, MP; Dvorácskó, S; Minosi, P; Mollica, A; Pieretti, S; Stefanucci, A; Tömböly, C; Zengin, G1
Bush, JM; Cabanlong, CV; Fantegrossi, WE; Fujiwara, R; Fukuda, S; Gogoi, J; Jackson, BK; McCain, K; Pinson, A; Prather, PL; Radominska-Pandya, A; Shoeib, A; Yarbrough, AL1
Kinsey, SG; Poklis, JL; Trexler, KR; Vanegas, SO1
Fantegrossi, WE; Hiranita, T; Wilson, CD1
Fantegrossi, WE; Wilson, CD; Zheng, F1

Other Studies

8 other study(ies) available for indazoles and sr141716

ArticleYear
Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
    Synapse (New York, N.Y.), 2002, Dec-01, Volume: 46, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Analysis of Variance; Animals; Arachidonic Acids; Biguanides; Cannabinoids; Chelating Agents; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electrophysiology; Endocannabinoids; Enzyme Inhibitors; Female; Indazoles; Membrane Potentials; Oocytes; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Serotonin, 5-HT3; Rimonabant; RNA, Complementary; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin Receptor Agonists; Thionucleotides; Tropanes; Xenopus laevis

2002
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors.
    Bioorganic & medicinal chemistry, 2005, May-02, Volume: 13, Issue:9

    Topics: Animals; Cannabinoid Receptor Antagonists; Gastrointestinal Transit; Indazoles; Ligands; Mice; Mice, Inbred ICR; Molecular Structure; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Structure-Activity Relationship

2005
NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
    Behavioural brain research, 2012, Oct-01, Volume: 234, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Body Weight; Brain-Derived Neurotrophic Factor; Cannabinoid Receptor Antagonists; Cholesterol; Dietary Fats; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypothalamus; Indazoles; Intra-Abdominal Fat; Liver; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin Plasma Membrane Transport Proteins; Thiophenes; Transaminases; Triglycerides

2012
Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity.
    Biomolecules, 2019, 09-16, Volume: 9, Issue:9

    Topics: Animals; Disease Models, Animal; Edema; Feeding Behavior; Indazoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Molecular Structure; Rats; Receptors, Cannabinoid; Rimonabant; Valine; Zymosan

2019
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
    Pharmacology, biochemistry, and behavior, 2020, Volume: 195

    Topics: Adamantane; Animals; Cannabinoid Receptor Antagonists; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Indazoles; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxidation-Reduction; Polymorphism, Genetic; Protein Binding; Receptor, Cannabinoid, CB1; Recombinant Proteins; Rimonabant; Sex Factors

2020
The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
    Drug and alcohol dependence, 2020, 09-01, Volume: 214

    Topics: Animals; Cannabinoids; Dronabinol; Drug Tolerance; Indazoles; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders; Tandem Mass Spectrometry

2020
Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
    Drug and alcohol dependence, 2022, 07-01, Volume: 236

    Topics: Amides; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Humans; Hypothermia; Indazoles; Male; Mice; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders; Tremor; Valine

2022
Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice.
    Psychopharmacology, 2022, Volume: 239, Issue:10

    Topics: Animals; Benzodiazepines; Cannabinoid Receptor Agonists; Cannabinoids; Convulsants; Diazepam; Electroencephalography; Humans; Indazoles; Indoles; Male; Mice; Naphthalenes; Pentylenetetrazole; Receptor, Cannabinoid, CB1; Rimonabant; Seizures; Substance-Related Disorders; Valine

2022